Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Claudia Lin, Ph.D (she/her/hers)

Executive VP
Pharmatech Associates, a USP Company
San Ramon, California

Dr. Claudia Lin, Executive VP for Pharmatech Associates, a USP Company, received her Ph.D in cell and molecular biology from UC Berkeley. She started her career in biotech industry in translational research and drug development. Over the past 25 years, she became an industry leading expert in biologics product development and quality management holding several CMC and quality leadership positions at Genentech, ROCHE, and Bayer Healthcare in the US. A decade ago, Claudia took her Western biopharma expertise to China, where she played a critical role in the evolution of China’s biotech industry, especially in GMP manufacturing, quality & regulatory compliance. Her CMC consulting company in China played instrumental roles in supporting many of the "China-first for global" product launches for biologics and cell and gene therapy products. Her leadership in bridging China and the West won a strategic alliance with a leading global CDMO for biologics QC testing service platform, further solidifying her influence on the Chinese biotech industry. Since returning to the US in 2024, Claudia is serving the global biologics community as a seasoned business development and technical advisor helping innovative drug developers around the world advance their product development through strategic and technical consulting.

Disclosure information not submitted.

Presentation(s):